Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses
•Viral load in upper respiratory tract samples were below the detection levels by day 8.•Saliva samples were not as efficient in detecting viral RNA as Nasopharyngeal and oropharyngeal swabs.•Neutralizing antibodies correlated with reduction in viral load.•Mild COVID-19 infections show absence of in...
Gespeichert in:
Veröffentlicht in: | Journal of clinical virology 2022-01, Vol.146, p.105060-105060, Article 105060 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 105060 |
---|---|
container_issue | |
container_start_page | 105060 |
container_title | Journal of clinical virology |
container_volume | 146 |
creator | Anantharaj, Anbalagan Gujjar, Sunil Verma, Nikhil Khan, Naseem Ahmed Shaman, Heena Sharanabasava, Patil Das, Asim Pandey, Rajesh Pandey, Anil Kumar Medigeshi, Guruprasad R. |
description | •Viral load in upper respiratory tract samples were below the detection levels by day 8.•Saliva samples were not as efficient in detecting viral RNA as Nasopharyngeal and oropharyngeal swabs.•Neutralizing antibodies correlated with reduction in viral load.•Mild COVID-19 infections show absence of inflammatory markers but increase in IL-7 and IL-8.•Patients recovered in the absence of detectable antibodies suggesting a protective role for innate immunity and T-cell responses.
Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized. We have collected serial samples from 23 hospitalized COVID-19 patients with mild symptoms and measured the kinetics of SARS-CoV-2 viral load in respiratory samples and markers of inflammation in serum samples. We monitored seroconversion during the acute phase of illness and quantitated the amount of total IgG against the receptor-binding domain of SARS-CoV-2 and estimated the virus neutralization potential of these antibodies. Viral load decreased by day 8 in all the patients but the detection of viral RNA in saliva samples did not correlate well with viral RNA detection in nasopharyngeal/oropharyngeal swab samples. 25% of the virus-positive patients had no detectable neutralizing antibodies in the serum and in other cases, the efficiency of antibodies to neutralize SARS-CoV-2 B1.1.7 strain was lower as compared to the circulating virus isolate. Decrease in viral load coincided with increase in neutralizing antibodies and interferon levels in serum. Most patients showed no increase in inflammatory cytokines such as IL-1β or IL-6, however, elevated levels of IL-7 and other inflammatory mediators such as TNF-α and IL-8 was observed. These data suggest that most mild infections are associated with absence of inflammation coupled with an active innate immune response, T-cell activation and neutralizing antibodies. |
doi_str_mv | 10.1016/j.jcv.2021.105060 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1386653221003279</els_id><sourcerecordid>2615917720</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-1b7d403f2c4b5ed5d6a2a5a39db509164f6dfa58809fcaf1ad3fdc19d00c8be33</originalsourceid><addsrcrecordid>eNp9kU1vFSEUhonR2Fr9AW4MSzdzhWFghpiYmOtXkyZNmuqWMHCw3MzACMwY_700tzbtxg2f73k5vA9CrynZUULFu8PuYLZdS1pa95wI8gSd0qFnDZeif1rXbBCN4Kw9QS9yPhBCOev65-iEdbKnQydPUbyCHKe1-BhwdHjzSU94itpiH_DsJ4v3lz_OPzVU4kUXD6Fk7DPWOUfjdQGLf_tyg8dYBx9CPcE6WKytXorfAPt5XgPgBHmJIUN-iZ45PWV4dTefoe9fPl_vvzUXl1_P9x8vGtNxWho69rYjzLWmGzlYboVuNddM2pETSUXnhHWaDwORzmhHtWXOGiotIWYYgbEz9OHou6zjDNbUxuvP1JL8rNMfFbVXj2-Cv1E_46YGMfQ1m2rw9s4gxV8r5KJmnw1Mkw4Q16xaQbmkfd-SKqVHqUkx5wTu_hlK1C0odVAVlLoFpY6gas2bh_3dV_wjUwXvjwKoKW0eksqmxm_A-gSmKBv9f-z_AmDzplQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2615917720</pqid></control><display><type>article</type><title>Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Anantharaj, Anbalagan ; Gujjar, Sunil ; Verma, Nikhil ; Khan, Naseem Ahmed ; Shaman, Heena ; Sharanabasava, Patil ; Das, Asim ; Pandey, Rajesh ; Pandey, Anil Kumar ; Medigeshi, Guruprasad R.</creator><creatorcontrib>Anantharaj, Anbalagan ; Gujjar, Sunil ; Verma, Nikhil ; Khan, Naseem Ahmed ; Shaman, Heena ; Sharanabasava, Patil ; Das, Asim ; Pandey, Rajesh ; Pandey, Anil Kumar ; Medigeshi, Guruprasad R.</creatorcontrib><description>•Viral load in upper respiratory tract samples were below the detection levels by day 8.•Saliva samples were not as efficient in detecting viral RNA as Nasopharyngeal and oropharyngeal swabs.•Neutralizing antibodies correlated with reduction in viral load.•Mild COVID-19 infections show absence of inflammatory markers but increase in IL-7 and IL-8.•Patients recovered in the absence of detectable antibodies suggesting a protective role for innate immunity and T-cell responses.
Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized. We have collected serial samples from 23 hospitalized COVID-19 patients with mild symptoms and measured the kinetics of SARS-CoV-2 viral load in respiratory samples and markers of inflammation in serum samples. We monitored seroconversion during the acute phase of illness and quantitated the amount of total IgG against the receptor-binding domain of SARS-CoV-2 and estimated the virus neutralization potential of these antibodies. Viral load decreased by day 8 in all the patients but the detection of viral RNA in saliva samples did not correlate well with viral RNA detection in nasopharyngeal/oropharyngeal swab samples. 25% of the virus-positive patients had no detectable neutralizing antibodies in the serum and in other cases, the efficiency of antibodies to neutralize SARS-CoV-2 B1.1.7 strain was lower as compared to the circulating virus isolate. Decrease in viral load coincided with increase in neutralizing antibodies and interferon levels in serum. Most patients showed no increase in inflammatory cytokines such as IL-1β or IL-6, however, elevated levels of IL-7 and other inflammatory mediators such as TNF-α and IL-8 was observed. These data suggest that most mild infections are associated with absence of inflammation coupled with an active innate immune response, T-cell activation and neutralizing antibodies.</description><identifier>ISSN: 1386-6532</identifier><identifier>ISSN: 1873-5967</identifier><identifier>EISSN: 1873-5967</identifier><identifier>DOI: 10.1016/j.jcv.2021.105060</identifier><identifier>PMID: 34971849</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antibodies ; Antibodies, Viral ; COVID-19 ; Cytokines ; Humans ; Immunity ; Inflammation ; PRNT ; SARS-CoV-2 ; Viral Load</subject><ispartof>Journal of clinical virology, 2022-01, Vol.146, p.105060-105060, Article 105060</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><rights>2021 Elsevier B.V. All rights reserved. 2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-1b7d403f2c4b5ed5d6a2a5a39db509164f6dfa58809fcaf1ad3fdc19d00c8be33</citedby><cites>FETCH-LOGICAL-c451t-1b7d403f2c4b5ed5d6a2a5a39db509164f6dfa58809fcaf1ad3fdc19d00c8be33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jcv.2021.105060$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34971849$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anantharaj, Anbalagan</creatorcontrib><creatorcontrib>Gujjar, Sunil</creatorcontrib><creatorcontrib>Verma, Nikhil</creatorcontrib><creatorcontrib>Khan, Naseem Ahmed</creatorcontrib><creatorcontrib>Shaman, Heena</creatorcontrib><creatorcontrib>Sharanabasava, Patil</creatorcontrib><creatorcontrib>Das, Asim</creatorcontrib><creatorcontrib>Pandey, Rajesh</creatorcontrib><creatorcontrib>Pandey, Anil Kumar</creatorcontrib><creatorcontrib>Medigeshi, Guruprasad R.</creatorcontrib><title>Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses</title><title>Journal of clinical virology</title><addtitle>J Clin Virol</addtitle><description>•Viral load in upper respiratory tract samples were below the detection levels by day 8.•Saliva samples were not as efficient in detecting viral RNA as Nasopharyngeal and oropharyngeal swabs.•Neutralizing antibodies correlated with reduction in viral load.•Mild COVID-19 infections show absence of inflammatory markers but increase in IL-7 and IL-8.•Patients recovered in the absence of detectable antibodies suggesting a protective role for innate immunity and T-cell responses.
Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized. We have collected serial samples from 23 hospitalized COVID-19 patients with mild symptoms and measured the kinetics of SARS-CoV-2 viral load in respiratory samples and markers of inflammation in serum samples. We monitored seroconversion during the acute phase of illness and quantitated the amount of total IgG against the receptor-binding domain of SARS-CoV-2 and estimated the virus neutralization potential of these antibodies. Viral load decreased by day 8 in all the patients but the detection of viral RNA in saliva samples did not correlate well with viral RNA detection in nasopharyngeal/oropharyngeal swab samples. 25% of the virus-positive patients had no detectable neutralizing antibodies in the serum and in other cases, the efficiency of antibodies to neutralize SARS-CoV-2 B1.1.7 strain was lower as compared to the circulating virus isolate. Decrease in viral load coincided with increase in neutralizing antibodies and interferon levels in serum. Most patients showed no increase in inflammatory cytokines such as IL-1β or IL-6, however, elevated levels of IL-7 and other inflammatory mediators such as TNF-α and IL-8 was observed. These data suggest that most mild infections are associated with absence of inflammation coupled with an active innate immune response, T-cell activation and neutralizing antibodies.</description><subject>Antibodies</subject><subject>Antibodies, Viral</subject><subject>COVID-19</subject><subject>Cytokines</subject><subject>Humans</subject><subject>Immunity</subject><subject>Inflammation</subject><subject>PRNT</subject><subject>SARS-CoV-2</subject><subject>Viral Load</subject><issn>1386-6532</issn><issn>1873-5967</issn><issn>1873-5967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1vFSEUhonR2Fr9AW4MSzdzhWFghpiYmOtXkyZNmuqWMHCw3MzACMwY_700tzbtxg2f73k5vA9CrynZUULFu8PuYLZdS1pa95wI8gSd0qFnDZeif1rXbBCN4Kw9QS9yPhBCOev65-iEdbKnQydPUbyCHKe1-BhwdHjzSU94itpiH_DsJ4v3lz_OPzVU4kUXD6Fk7DPWOUfjdQGLf_tyg8dYBx9CPcE6WKytXorfAPt5XgPgBHmJIUN-iZ45PWV4dTefoe9fPl_vvzUXl1_P9x8vGtNxWho69rYjzLWmGzlYboVuNddM2pETSUXnhHWaDwORzmhHtWXOGiotIWYYgbEz9OHou6zjDNbUxuvP1JL8rNMfFbVXj2-Cv1E_46YGMfQ1m2rw9s4gxV8r5KJmnw1Mkw4Q16xaQbmkfd-SKqVHqUkx5wTu_hlK1C0odVAVlLoFpY6gas2bh_3dV_wjUwXvjwKoKW0eksqmxm_A-gSmKBv9f-z_AmDzplQ</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Anantharaj, Anbalagan</creator><creator>Gujjar, Sunil</creator><creator>Verma, Nikhil</creator><creator>Khan, Naseem Ahmed</creator><creator>Shaman, Heena</creator><creator>Sharanabasava, Patil</creator><creator>Das, Asim</creator><creator>Pandey, Rajesh</creator><creator>Pandey, Anil Kumar</creator><creator>Medigeshi, Guruprasad R.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220101</creationdate><title>Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses</title><author>Anantharaj, Anbalagan ; Gujjar, Sunil ; Verma, Nikhil ; Khan, Naseem Ahmed ; Shaman, Heena ; Sharanabasava, Patil ; Das, Asim ; Pandey, Rajesh ; Pandey, Anil Kumar ; Medigeshi, Guruprasad R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-1b7d403f2c4b5ed5d6a2a5a39db509164f6dfa58809fcaf1ad3fdc19d00c8be33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Antibodies, Viral</topic><topic>COVID-19</topic><topic>Cytokines</topic><topic>Humans</topic><topic>Immunity</topic><topic>Inflammation</topic><topic>PRNT</topic><topic>SARS-CoV-2</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anantharaj, Anbalagan</creatorcontrib><creatorcontrib>Gujjar, Sunil</creatorcontrib><creatorcontrib>Verma, Nikhil</creatorcontrib><creatorcontrib>Khan, Naseem Ahmed</creatorcontrib><creatorcontrib>Shaman, Heena</creatorcontrib><creatorcontrib>Sharanabasava, Patil</creatorcontrib><creatorcontrib>Das, Asim</creatorcontrib><creatorcontrib>Pandey, Rajesh</creatorcontrib><creatorcontrib>Pandey, Anil Kumar</creatorcontrib><creatorcontrib>Medigeshi, Guruprasad R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anantharaj, Anbalagan</au><au>Gujjar, Sunil</au><au>Verma, Nikhil</au><au>Khan, Naseem Ahmed</au><au>Shaman, Heena</au><au>Sharanabasava, Patil</au><au>Das, Asim</au><au>Pandey, Rajesh</au><au>Pandey, Anil Kumar</au><au>Medigeshi, Guruprasad R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses</atitle><jtitle>Journal of clinical virology</jtitle><addtitle>J Clin Virol</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>146</volume><spage>105060</spage><epage>105060</epage><pages>105060-105060</pages><artnum>105060</artnum><issn>1386-6532</issn><issn>1873-5967</issn><eissn>1873-5967</eissn><abstract>•Viral load in upper respiratory tract samples were below the detection levels by day 8.•Saliva samples were not as efficient in detecting viral RNA as Nasopharyngeal and oropharyngeal swabs.•Neutralizing antibodies correlated with reduction in viral load.•Mild COVID-19 infections show absence of inflammatory markers but increase in IL-7 and IL-8.•Patients recovered in the absence of detectable antibodies suggesting a protective role for innate immunity and T-cell responses.
Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized. We have collected serial samples from 23 hospitalized COVID-19 patients with mild symptoms and measured the kinetics of SARS-CoV-2 viral load in respiratory samples and markers of inflammation in serum samples. We monitored seroconversion during the acute phase of illness and quantitated the amount of total IgG against the receptor-binding domain of SARS-CoV-2 and estimated the virus neutralization potential of these antibodies. Viral load decreased by day 8 in all the patients but the detection of viral RNA in saliva samples did not correlate well with viral RNA detection in nasopharyngeal/oropharyngeal swab samples. 25% of the virus-positive patients had no detectable neutralizing antibodies in the serum and in other cases, the efficiency of antibodies to neutralize SARS-CoV-2 B1.1.7 strain was lower as compared to the circulating virus isolate. Decrease in viral load coincided with increase in neutralizing antibodies and interferon levels in serum. Most patients showed no increase in inflammatory cytokines such as IL-1β or IL-6, however, elevated levels of IL-7 and other inflammatory mediators such as TNF-α and IL-8 was observed. These data suggest that most mild infections are associated with absence of inflammation coupled with an active innate immune response, T-cell activation and neutralizing antibodies.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34971849</pmid><doi>10.1016/j.jcv.2021.105060</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1386-6532 |
ispartof | Journal of clinical virology, 2022-01, Vol.146, p.105060-105060, Article 105060 |
issn | 1386-6532 1873-5967 1873-5967 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687718 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antibodies Antibodies, Viral COVID-19 Cytokines Humans Immunity Inflammation PRNT SARS-CoV-2 Viral Load |
title | Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A21%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resolution%20of%20viral%20load%20in%20mild%20COVID-19%20patients%20is%20associated%20with%20both%20innate%20and%20adaptive%20immune%20responses&rft.jtitle=Journal%20of%20clinical%20virology&rft.au=Anantharaj,%20Anbalagan&rft.date=2022-01-01&rft.volume=146&rft.spage=105060&rft.epage=105060&rft.pages=105060-105060&rft.artnum=105060&rft.issn=1386-6532&rft.eissn=1873-5967&rft_id=info:doi/10.1016/j.jcv.2021.105060&rft_dat=%3Cproquest_pubme%3E2615917720%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2615917720&rft_id=info:pmid/34971849&rft_els_id=S1386653221003279&rfr_iscdi=true |